Arkea Bio
Charlestown, US · Founded 2021 · Delaware corporation
Founders & leadership
FW
Frank WootenNamed on SEC filing
ZS
Zachariah SerberNamed on SEC filing
GS
Ginja SilvaNamed on SEC filing
MD
Matthew DunnNamed on SEC filing
CS
Colin SouthNamed on SEC filing
Board
WM
Wayne McNeeBoard director
CR
Chris RivestBoard director
Reported raises · per SEC filings
Form D private placements$7M disclosed across 1 of 2 rounds · 2023–2025
▶$7MraisedOct 2025 · 2 investors · Other TechnologyRule 506(b)
▶$7MraisedOct 2025 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Frank WootenExecutive Officer, Director
- Wayne McNeeDirector
- Chris RivestExecutive Officer, Director
- Zachariah SerberExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $7M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶Undisclosed amountofferedDec 2023 · Other TechnologyRule 506(b)
▶Undisclosed amountofferedDec 2023 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ginja SilvaExecutive Officer
- Chris RivestExecutive Officer, Director
- Matthew DunnExecutive Officer
- Zachariah SerberDirector
- Colin SouthExecutive Officer, Director
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Arkea Bio raised?
- Arkea Bio has disclosed $7M raised across 1 of its 2 known rounds.
- Where is Arkea Bio headquartered?
- Arkea Bio is headquartered in Charlestown, US.